Brand profile · Biotechnology Research

Celosia Therapeutics

Celosia Therapeutics is a Biotechnology Research brand in Sydney, New South Wales. Ownership is privately held; it publishes at celosiatx.com. It holds one address on record, all in Australia. The record counts 5 people. One Australian registration (ABN) is a confirmed match. Its latest round on record is Series A, US$16.8M. It is listed alongside five similar brands, mostly in Biotechnology Research.

celosiatx.com LinkedIn

Profile live Privately Held Founded 2022 1 entity ABN 1 office country US$ 16.8M Series A
Registry verified · ABR
Counted staff
5
self-reported 1–1 band
Founded
2022
4 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
2
Series A · Dec 2024 · US$ 16.8M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

  • CELOSIA THERAPEUTICS PTY LIMITED

    ABN87662867361

    NSWHigh confidenceMatched on exact nameABR

Legal entities

Celosia Therapeutics: 1 registry entityCelosia Therapeutics is linked to 1 registry entity: CELOSIA THERAPEUTICS PTY LIMITED (ABN 87662867361, candidate).Celosia TherapeuticsCELOSIA THERAPEUTICSPTY LIMITEDABN 87662867361Candidate · High confidence
Show as table
CELOSIA THERAPEUTICS PTY LIMITEDABN 87662867361
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Celosia Therapeutics is a privately held pre-clinical stage gene therapy company, developing solutions for neurodegenerative diseases that have limited alternative therapeutic options.

Locations

Australiaprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUSydney, New South WalesPrimary

Grid intelligence Members

Funding

Last round · 27 December 2024US$ 16.8MSeries A · investor: Uniseed
Rounds2
Round typeSeries A · venture round
Amount (USD)16,800,000
Stage rank3
Investors named1
Since last round1 yr

Funding

2 funding roundsFunding timeline. Latest round 27 Dec 2024: Series A, US$ 16.8M.20222026Series AUS$ 16.8M2 rounds
Show as table
Rounds2
Axis2022 to 2026
Series A · 27 Dec 2024US$ 16.8M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

4 employee profiles on record · names withheld.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Celosia Therapeutics?

One New South Wales entity on the ABR. CELOSIA THERAPEUTICS PTY LIMITED (ABN 87 662 867 361), high confidence.

How many people work at Celosia Therapeutics?

The record holds 5 counted staff profiles at January 2026, above the self-reported 1 band.

Where does Celosia Therapeutics have offices?

One address on record, Australia only. Primary: Sydney, New South Wales.

Has Celosia Therapeutics raised funding?

Two rounds. Latest 27 December 2024: Series A, US$16,800,000, investor Uniseed.

Which companies are listed alongside Celosia Therapeutics?

Five peer profiles on record: FPA Patent Attorneys and Neurizon Therapeutics Limited.

What is Celosia Therapeutics's website?

celosiatx.com